Goldfarb Branham Law Firm LLP Investigating Medco Health Solutions, Inc.

DALLAS--(BUSINESS WIRE)--Goldfarb Branham LLP is investigating whether the board of directors of Medco Health Solutions, Inc. (NYSE: MHS) violated shareholder protection laws by agreeing to a buyout by Express Scripts, Inc. for value of $74.14 per share in cash and stock. Concerned Medco investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbbranham.com about their rights and remedies.

“This buyout prompted our investigation for shareholders because analysts have projected that MHS stock value is targeted as high as $80 and EBITDA and EBIT multiples are undervalued,” securities lawyer Hamilton Lindley said. “Our proposed shareholder class action lawsuit seeks to ensure that the buyout is fair to shareholders – both in terms of price and information.”

Goldfarb Branham LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. Medco Health Solutions investors – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at hlindley@goldfarbbranham.com or 877-583-2855.